|
|
DISCUSSION
Genetic modification of mice embryos to produce mice
deficient for Fgf10 lacked limb buds. This revealed
that FGF10 is necessary for limb bud initiation. Treating
embryos with SU5402 (final concentration 5 uM) did not
inhibit limb bud outgrowth. This lead us to conclude that we
did not completely inhibit FGF signaling and/or FGFR
activity was restored some point after treatment before limb
bud initiation. A possible way to remedy this result would
be to reinject embros after the initial treatment or to
treat the embryos at a time crucial to limb bud
initiation.
It has been demonstrated that mesodermal Fgf-10 initiates
limb bud outgrowth and initiates the expression
ofFgf8in
the AER which subsequently upregulates
Shhin the posterior
margin or the developing limb bud. Subsequently, SHH
upregulates Fgf4in the
AER which in turn positively regulates Shh in the posterior
limb. Furthermore, Sanz-Ezquerro and colleagues have
demonstrated that SHH participates in an auto regulatory
feedback loop in the limb bud (2000). When they ectopically
expressed shh, they found that
shhwas subsequently
downregulated (Sanz-Ezquerro et al. 2000). As indicated by
the high level of shh expression in the limb buds, we
suspect that the FGF inhibition interfered with the
autoregulatory mechanism of SHH (Figure 4).
Previous research indicates that mutations in FGFR1, FGFR2,
and FGFR 3 result in cranial malformations that involve
multiple or all sutures (Wilkie 1997; as cited by
|
|